Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF) Short Interest Update

Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF) saw a significant growth in short interest in the month of May. As of May 31st, there was short interest totalling 704,500 shares, a growth of 49.7% from the May 15th total of 470,600 shares. Based on an average trading volume of 0 shares, the short-interest ratio is currently ∞ days.

Recordati Industria Chimica e Farmaceutica Stock Performance

Shares of RCDTF remained flat at $51.60 during mid-day trading on Friday. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.86 and a current ratio of 1.28. Recordati Industria Chimica e Farmaceutica has a 1 year low of $51.60 and a 1 year high of $51.98. The firm’s 50 day simple moving average is $51.60 and its 200 day simple moving average is $49.99.

About Recordati Industria Chimica e Farmaceutica

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, and marketing of pharmaceuticals worldwide. The company operates through Specialty and Primary Care and Rare Diseases segments. Its product pipeline includes REC 0559 which is in Phase II for the treatment of Neurotrophic Keratitis; REC 0545 for acute decompensation in maple syrup urine diseases; ISTURISA for endogenous Cushing's syndrome; and CYSTADROPS, an corneal cystine deposits in patients with cystinosis.